SCHEMBL2641922

SCHEMBL2641922

CN(C)c1ccc(/C=C/c2cccc(Br)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.57
MEN1 O00255 4/20 0.57
RAB9A P51151 4/20 0.57
KMT2A Q03164 4/20 0.57
KDM4E B2RXH2 1/20 0.57
MAPK1 P28482 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
RELA Q04206 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 2/20 0.50
CASP1 P29466 2/20 0.50
HBB P68871 2/20 0.50
ALOX15 P16050 1/20 0.50
MAT2A P31153 1/20 0.49
KCNH2 Q12809 1/20 0.49
APP P05067 11/20 0.47
EGFR P00533 1/20 0.45
S100A4 P26447 1/20 0.44
INSR P06213 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2641926 1.00 MAPT (0.57) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL2641792 0.83 EGFR (0.43) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL2641899 0.81 MAPT (0.57) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL12185950 0.81 MAPT (0.57) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL2641835 0.81 MAPT (0.57) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL2641832 0.81 MAPT (0.57) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL2641895 0.81 MAPT (0.57) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL4542155 0.79 GRM4 (0.61) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL4542158 0.79 GRM4 (0.61) MAPTMEN1RAB9AKMT2AKDM4E
SCHEMBL2641784 0.77 MAPT (0.56) MAPTMEN1RAB9AKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011141515-A1 DIAGNOSTIC AGENTS FOR AMYLOID BETA IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-11-17 WO disclosed
WO-2011141515-A1 DIAGNOSTIC AGENTS FOR AMYLOID BETA IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2011-11-17 WO disclosed